| Comprehensive review of chromophobe renal cell carcinoma R Garje, D Elhag, HA Yasin, L Acharya, D Vaena, L Dahmoush Critical reviews in oncology/hematology 160, 103287, 2021 | 74 | 2021 |
| Obesity diminishes response to PD-1-based immunotherapies in renal cancer SK Boi, RM Orlandella, JT Gibson, WJ Turbitt, G Wald, L Thomas, ... Journal for immunotherapy of cancer 8 (2), 2020 | 65 | 2020 |
| Fibroblast growth factor receptor (FGFR) inhibitors in urothelial cancer R Garje, J An, M Obeidat, K Kumar, HA Yasin, Y Zakharia The oncologist 25 (11), e1711-e1719, 2020 | 40 | 2020 |
| Psychometric properties of the Arabic version of EORTC QLQ-C15-PAL among cancer patients in Jordan A Alawneh, H Yasin, G Khirfan, BA Qayas, K Ammar, D Rimawi, ... Supportive care in cancer 24, 2455-2462, 2016 | 26 | 2016 |
| Symptom prevalence of patients with cancer in a tertiary cancer center in Jordan A Alawneh, H Anshasi, G Khirfan, H Yaseen, A Quran Age 18 (34), 27, 2017 | 14 | 2017 |
| The association between a decrease in on-treatment neutrophil-to-eosinophil ratio (NER) at week 6 after ipilimumab plus nivolumab initiation and improved clinical outcomes in … YW Chen, MD Tucker, LC Brown, HA Yasin, KK Ancell, AJ Armstrong, ... Cancers 14 (15), 3830, 2022 | 7 | 2022 |
| Artificial intelligence modelling to assess the risk of cardiovascular disease in oncology patients SS Al-Droubi, E Jahangir, KM Kochendorfer, M Krive, M Laufer-Perl, ... European Heart Journal-Digital Health 4 (4), 302-315, 2023 | 5 | 2023 |
| Metastatic renal cell carcinoma to the spine: outcomes and morbidity: single-center experience BJ Park, SC Seaman, JL Noeller, MC Smith, DM Hasan, H Yasin, ... World neurosurgery 154, e398-e405, 2021 | 5 | 2021 |
| A Rare Case of Midostaurin‐Associated Sweet’s Syndrome H Yasin, T Laytem, G Sutamtewagul, S Ayyappan Case reports in hematology 2022 (1), 1099005, 2022 | 4 | 2022 |
| Avelumab in Combination with Eribulin Mesylate in Metastatic Urothelial Carcinoma: BTCRC GU-051, a Phase 1b Study M Joshi, SL Holder, J Zhu, H Zheng, S Komanduri, J Warrick, H Yasin, ... European urology focus 8 (2), 483-490, 2022 | 3 | 2022 |
| BCG-unresponsive NMIBC: Current evidence and options MD Woodson W. Smelser, MD, Hesham A. Yasin, MD, Nancy B. Davis Urology Times Urologists in Cancer Care 10 (04), 2021 | 3* | 2021 |
| An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy F Farooq, JS Brandt, E Cardonick, E Polushkina, J Vose, S Ahmed, ... Blood advances 7 (18), 5480-5484, 2023 | 2 | 2023 |
| Association between decline of neutrophil-to-eosinophil ratio (NER) at week 6 after ipilimumab plus nivolumab initiation and improved clinical outcomes in metastatic renal cell … YW Chen, MD Tucker, LC Brown, HA Yasin, KK Ancell, AJ Armstrong, ... Journal of Clinical Oncology 40 (16_suppl), 4527-4527, 2022 | 2 | 2022 |
| 427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma J Jain, M Frees, H Yasin, J Bonner, M Freesmeier, R Garje, VA Venur, ... Journal for immunotherapy of cancer 8 (Suppl 3), 2020 | 1 | 2020 |
| Impact of PSMA-targeted PET/CT in the clinical management of men with advanced prostate cancer. MD Tucker, YW Chen, HA Yasin, KK Ancell, DA Barocas, K Beckermann, ... Journal of Clinical Oncology 40 (16_suppl), e17053-e17053, 2022 | | 2022 |
| Improved overall survival of metastatic cancers in the United States across all age groups in the immunotherapy era: Implications for considering elderly patients (age≥ 75 … YW Chen, MD Tucker, HA Yasin, X Guo, XO Shu, BI Rini Journal of Clinical Oncology 40 (16_suppl), 12039-12039, 2022 | | 2022 |
| Association between tumor burden and response to immunotherapy in patients with metastatic renal cell carcinoma. HA Yasin, YW Chen, MD Tucker, K Beckermann, K Schaffer, NB Davis, ... Journal of Clinical Oncology 40 (16_suppl), 4541-4541, 2022 | | 2022 |
| Association between on-treatment eosinophil dynamics and outcomes in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab. YW Chen, MD Tucker, H Yasin, KK Ancell, NB Davis, SM Haake, E Kaiser, ... Journal of Clinical Oncology 40 (6_suppl), 364-364, 2022 | | 2022 |
| Oligometastatic papillary urothelial carcinoma with FGFR2 and FGFR3 mutations: Case series of four patients and review of the literature H Yasin, N Davis, J Gordetsky, S York, YW Chen, K Schaffer J Clin Images Med Case Rep 3 (12), 2183, 2022 | | 2022 |
| A Multi-Institution Analysis of Relapsed Lymphoma Occurring during Pregnancy Including Pharmacokinetics with Antenatal Checkpoint Inhibitor Therapy F Farooq, E Cardonick, E Polushkina, S Ahmed, P Ramakrishnan, ... Blood 138, 2457, 2021 | | 2021 |
Rohan GarjeAssociate Professor FIU, Chief of Genitourinary Medical Oncology, Miami cancer Institute在 uiowa.edu 的电子邮件经过验证
